Deciphera Pharmaceuticals, Inc. (DCPH): Price and Financial Metrics
DCPH Price/Volume Stats
| Current price | $25.59 | 52-week high | $25.61 |
| Prev. close | $25.57 | 52-week low | $9.90 |
| Day low | $25.56 | Volume | 1,596,000 |
| Day high | $25.61 | Avg. volume | 1,292,551 |
| 50-day MA | $21.27 | Dividend yield | N/A |
| 200-day MA | $15.80 | Market Cap | 2.21B |
DCPH Stock Price Chart Interactive Chart >
Deciphera Pharmaceuticals, Inc. (DCPH) Company Bio
Deciphera Pharmaceuticals LLC develops and manufactures kinase inhibitor treatments for cancer by cutting off the ability of tumor cells to thrive and spread. Its product pipeline includes Altiratinib (DCC-2701), a MET/TIE2/VEGFR2/TRK kinase inhibitor; DCC-2618, a pan-KIT inhibitor; Rebastinib, a TIE2/VEGFR1 kinase inhibitor; and LY3009120 (DP-4978), a pan-RAF inhibitor. The company was founded in 2003 and is based in Waltham, Massachusetts.
DCPH Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 56.32% |
| 3-year | 147.49% |
| 5-year | 50.09% |
| YTD | 58.65% |
| 2023 | -1.59% |
| 2022 | 67.76% |
| 2021 | -31.52% |
| 2020 | -8.31% |
| 2019 | 196.52% |
Continue Researching DCPH
Want to see what other sources are saying about Deciphera Pharmaceuticals Inc's financials and stock price? Try the links below:Deciphera Pharmaceuticals Inc (DCPH) Stock Price | Nasdaq
Deciphera Pharmaceuticals Inc (DCPH) Stock Quote, History and News - Yahoo Finance
Deciphera Pharmaceuticals Inc (DCPH) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...